Barrington Research Reiterates Outperform on Imax, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst James Goss has reiterated an Outperform rating on Imax (NYSE:IMAX) and maintained a $24 price target.
February 28, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research analyst James Goss has reiterated an Outperform rating on Imax and maintained a $24 price target.
The reiteration of an Outperform rating and the maintenance of a $24 price target by a reputable analyst could positively influence investor sentiment towards IMAX, potentially driving its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100